Literature DB >> 20664809

Exhaled nitric oxide in asthma: progress since the introduction of standardized methodology.

Natalia M Grob1, Raed A Dweik.   

Abstract

The measurement of nitric oxide (NO) in exhaled breath has given us the ability to learn about and monitor the inflammatory status of the airway through a non-invasive method that is easy to perform and repeat. This has been most useful in the diagnosis and management of asthma and has promised a seemingly unlimited potential for evaluating the airways and how clinical decisions are made (Grob N M and Dweik R A 2008 Chest133 837-9). The exhaled NO field was initially limited, however, due to the absence of standardized methodology. The ATS and ERS jointly released recommendations for standardized methods of measuring and reporting exhaled NO in 1999 that were revised in 2005 (1999 Am. J. Respir. Crit. Care. Med. 160 2104-17; 2005 Am. J. Respir. Crit. Care. Med. 171 912-30). In this paper, we summarize the literature that followed this standardization. We searched the literature for all papers that included the term 'exhaled nitric oxide' and selected those that followed ATS guidelines for online measurement for further review. We also reviewed cut-off values suggested by groups studying exhaled nitric oxide. We found a wide range of NO values reported for normal and asthma populations. The geometric mean for FE(NO) ranged from 10 ppb to 33 ppb in healthy adult control populations. For asthma, the FE(NO) geometric mean ranged from 6 ppb to 98 ppb. This considerable variation likely reflects the different clinical settings and purposes of measurement. Exhaled NO has been used for a multitude of reasons that range from screening, to diagnosis, to monitoring the effect of therapy. The field of exhaled NO has made undeniable progress since the standardization of the measurement methods. Our challenge now is to have guidelines to interpret exhaled NO levels in the appropriate context. As the utility of exhaled NO continues to evolve, it can serve as a good example of the crucial role of the standardization of collection and measurement methods to propel any new test in the right direction as it makes its way from a research tool to a clinically useful test.

Entities:  

Year:  2008        PMID: 20664809      PMCID: PMC2906817          DOI: 10.1088/1752-7155/2/3/037002

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  80 in total

1.  Exhaled nitric oxide predicts asthma exacerbation.

Authors:  Michelle S Harkins; Karen-Lynn Fiato; Gary K Iwamoto
Journal:  J Asthma       Date:  2004-06       Impact factor: 2.515

2.  Correlation of exhaled nitric oxide, spirometry and asthma symptoms.

Authors:  Jonathan M Spergel; Matthew I Fogg; Aleksandra Bokszczanin-Knosala
Journal:  J Asthma       Date:  2005-12       Impact factor: 2.515

3.  Assaying all of the nitrogen oxides in breath modifies the interpretation of exhaled nitric oxide.

Authors:  Thuy-Anh Nguyen; Jocelyn Woo-Park; Margaret Hess; Matthew Goins; Peter Urban; John Vaughan; Alison Smith; John Hunt
Journal:  Vascul Pharmacol       Date:  2005-10-10       Impact factor: 5.773

4.  Reduction of variability of exhaled nitric oxide in healthy volunteers.

Authors:  I van der Lee; J M M van den Bosch; P Zanen
Journal:  Respir Med       Date:  2002-12       Impact factor: 3.415

5.  Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.

Authors:  R H Green; C E Brightling; S McKenna; B Hargadon; N Neale; D Parker; C Ruse; I P Hall; I D Pavord
Journal:  Eur Respir J       Date:  2006-02-02       Impact factor: 16.671

6.  Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children.

Authors:  Angela Zacharasiewicz; Nicola Wilson; Christiane Lex; Edward M Erin; Albert M Li; Trevor Hansel; Mohammed Khan; Andrew Bush
Journal:  Am J Respir Crit Care Med       Date:  2005-02-11       Impact factor: 21.405

7.  Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humans.

Authors:  M G Belvisi; C D Stretton; M Yacoub; P J Barnes
Journal:  Eur J Pharmacol       Date:  1992-01-14       Impact factor: 4.432

8.  Exhaled nitric oxide rather than lung function distinguishes preschool children with probable asthma.

Authors:  L P Malmberg; A S Pelkonen; T Haahtela; M Turpeinen
Journal:  Thorax       Date:  2003-06       Impact factor: 9.139

Review 9.  Multiple roles of nitric oxide in the airways.

Authors:  F L M Ricciardolo
Journal:  Thorax       Date:  2003-02       Impact factor: 9.139

10.  Electrical field stimulation causes endothelium-dependent and nitric oxide-mediated relaxation of pulmonary artery.

Authors:  G M Buga; L J Ignarro
Journal:  Am J Physiol       Date:  1992-04
View more
  8 in total

1.  Clinical study of multiple breath biomarkers of asthma and COPD (NO, CO(2), CO and N(2)O) by infrared laser spectroscopy.

Authors:  Joanne H Shorter; David D Nelson; J Barry McManus; Mark S Zahniser; Susan R Sama; Donald K Milton
Journal:  J Breath Res       Date:  2011-07-15       Impact factor: 3.262

Review 2.  Cardiovascular biomarkers in exhaled breath.

Authors:  Frank S Cikach; Raed A Dweik
Journal:  Prog Cardiovasc Dis       Date:  2012 Jul-Aug       Impact factor: 8.194

3.  The great challenge for exhaled breath analysis: embracing complexity, delivering simplicity.

Authors:  Raed A Dweik
Journal:  J Breath Res       Date:  2011-09-07       Impact factor: 3.262

4.  Biomarkers in exhaled breath condensate: a review of collection, processing and analysis.

Authors:  N M Grob; M Aytekin; R A Dweik
Journal:  J Breath Res       Date:  2008-09-08       Impact factor: 3.262

5.  Exhaled breath analysis: The new interface between medicine and engineering.

Authors:  Alquam Mashir; Raed A Dweik
Journal:  Adv Powder Technol       Date:  2009-09       Impact factor: 4.833

6.  Breath analysis in pulmonary arterial hypertension.

Authors:  Frank S Cikach; Adriano R Tonelli; Jarrod Barnes; Kelly Paschke; Jennie Newman; David Grove; Luma Dababneh; Sihe Wang; Raed A Dweik
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

7.  Increased exhaled nitric oxide levels after exercise in patients with chronic systolic heart failure with pulmonary venous hypertension.

Authors:  Andres Schuster; Akanksha Thakur; Zeneng Wang; Allen G Borowski; James D Thomas; W H Wilson Tang
Journal:  J Card Fail       Date:  2012-10       Impact factor: 5.712

8.  Effects of add-on montelukast on airway hyperresponsiveness in patients with well-controlled asthma - a pilot study.

Authors:  Nina Kononowa; Sandra Michel; David Miedinger; Christiane E Pichler; Prashant N Chhajed; Arthur Helbling; Jörg D Leuppi
Journal:  J Drug Assess       Date:  2013-04-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.